A mouse model of focal cerebral ischemia for screening neuroprotective drug effects

Journal of Pharmacological and Toxicological Methods

Volumn 27, Issue 1, 1992, Pages 27-32

  Backhauß, Cord ^a   Karkoutly, Chourouk ^a   Welsch, Matthias ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 HT 1A agonists; Focal cerebral ischemia; Middle cerebral artery; Mouse; Neuroprotection; NMDA antagonists; Radical scavengers

Indexed keywords

1 (2 CYANOETHYL) 1,2,3,6 TETRAHYDRO 4 (3 TRIFLUOROMETHYLPHENYL)PYRIDINE; 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID METHYL TETRAHYDROFURFURYL ESTER; CALCIUM ANTAGONIST; CHLORPROMAZINE; DIHYDROLIPOATE; DIMETHYLTHIOUREA; DIZOCILPINE; EMOPAMIL; FURNIDIPINE; GINKGOLIDE B; IPSAPIRONE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; PHENCYCLIDINE; SCAVENGER; SEROTONIN AGONIST; THIOCTIC ACID; UNCLASSIFIED DRUG; VINPOCETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN SLICE; DRUG SCREENING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CEREBRAL ARTERIES; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ELECTROCOAGULATION; MALE; MICE; N-METHYLASPARTATE; SEROTONIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026507202     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8719(92)90017-U     Document Type: Article

References (29)

1. 1A receptors in brain
2. 3 Binding sites as a tool for the detection and quantification of brain lesions: Application to the evaluation of neuroprotective agents
3. Infarct reduction by NMDA antagonists in a rat stroke model
4. 1A Agonists show neuroprotectant activity in rats and mice
5. Is there a case for PAF antagonists in the treatment of ischemie states?
6. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture
7. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia
8. Excitatory amino acids, adenosine and neuronal calcium homeostasis—an overview
9. Pharmacology and drug therapy of cerebral ischemia
10. Protective effects of calcium antagonists against brain damage caused by ischemia
11. Tricyclic antidepressants block N-methyl-d-aspartic acid-induced lethality in mice
12. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats
13. (S)-Emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduced infarct size in rats with middle cerebral artery occlusion
14. Protective effect of nimodipine against neuronal damage caused by ischemia
15. 1A-agonist CM 57493 on infarct surface, infarct volume and hippocampal neuronal damage after focal and global cerebral ischemia in mice and in rats
16. Phencyclidin und Dimethylthioharnstoff reduzieren das Infarktvolumen im Rattenhirn nach fokaler Ischämie
17. PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus
18. Quantitative assessment of early brain damage in a rat model of focal cerebral ischemia
19. Dihydrolipoic acid protects neurons against ischemic/hypoxic damage
20. Dihydrolipoate reduces neuronal injury after cerebral ischemia
21. Vinpocetine ameliorates hippocampal neuronal damage following transient forebrain ischemia in the rat
22. Protective effects of vinpocetine against brain damage caused by focal or global cerebral ischemia
23. Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow
24. Neuroprotective effect of memantine demonstrated in vivo and in vitro
25. Blockade of N-methyl-d-aspartate receptors may protect against ischemie damage in the brain
26. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils
27. Focal cerebral ischemia in the rat: 1. Description of the technique and early neuropathological consequences following middle cerebral artery occlusion
28. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system
29. Effect of lactatacidosis on pyridine nucleotide stability during ischemia in mouse brain